Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-102814
Filing Date
2024-09-25
Accepted
2024-09-25 16:45:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2424891d1_sc13da.htm SC 13D/A 42314
  Complete submission text file 0001104659-24-102814.txt   43860
Mailing Address 375 PARK AVE NEW YORK NY 10152
Business Address
ROSENWALD LINDSAY A MD (Filed by) CIK: 0000941841 (see all company filings)

Type: SC 13D/A

Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Subject) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86661 | Film No.: 241325210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)